162 related articles for article (PubMed ID: 8600958)
1. Positron emission tomography in the diagnosis and staging of urinary bladder cancer.
Ahlström H; Malmström PU; Letocha H; Andersson J; Långström B; Nilsson S
Acta Radiol; 1996 Mar; 37(2):180-5. PubMed ID: 8600958
[TBL] [Abstract][Full Text] [Related]
2. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Golan S; Sopov V; Baniel J; Groshar D
J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
Jansson T; Westlin JE; Ahlström H; Lilja A; Långström B; Bergh J
J Clin Oncol; 1995 Jun; 13(6):1470-7. PubMed ID: 7751894
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Rodriguez M
Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
7. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT.
Geets X; Daisne JF; Gregoire V; Hamoir M; Lonneux M
Radiother Oncol; 2004 Jun; 71(3):267-73. PubMed ID: 15172141
[TBL] [Abstract][Full Text] [Related]
8. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Swinnen G; Maes A; Pottel H; Vanneste A; Billiet I; Lesage K; Werbrouck P
Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
[TBL] [Abstract][Full Text] [Related]
10. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.
Picchio M; Treiber U; Beer AJ; Metz S; Bössner P; van Randenborgh H; Paul R; Weirich G; Souvatzoglou M; Hartung R; Schwaiger M; Piert M
J Nucl Med; 2006 Jun; 47(6):938-44. PubMed ID: 16741302
[TBL] [Abstract][Full Text] [Related]
11. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.
Harney JV; Wahl RL; Liebert M; Kuhl DE; Hutchins GD; Wedemeyer G; Grossman HB
J Urol; 1991 Feb; 145(2):279-83. PubMed ID: 1988718
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
Bouchelouche K; Oehr P
J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography with L-methyl-11C-methionine in the monitoring of therapy response in muscle-invasive transitional cell carcinoma of the urinary bladder.
Letocha H; Ahlström H; Malmström PU; Westlin JE; Fasth KJ; Nilsson S
Br J Urol; 1994 Dec; 74(6):767-74. PubMed ID: 7827849
[TBL] [Abstract][Full Text] [Related]
14. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm P; Leskinen-Kallio S; Minn H; Bergman J; Haaparanta M; Lehikoinen P; Någren K; Ruotsalainen U; Teräs M; Joensuu H
J Nucl Med; 1993 Oct; 34(10):1711-6. PubMed ID: 8410288
[TBL] [Abstract][Full Text] [Related]
15. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
Kollberg P; Almquist H; Bläckberg M; Cronberg C; Garpered S; Gudjonsson S; Kleist J; Lyttkens K; Patschan O; Liedberg F
Scand J Urol; 2015; 49(4):296-301. PubMed ID: 25623843
[TBL] [Abstract][Full Text] [Related]
16. [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
Bachor R; Kocher F; Gropengiesser F; Reske SN; Hautmann RE
Urologe A; 1995 Mar; 34(2):138-42. PubMed ID: 7754585
[TBL] [Abstract][Full Text] [Related]
17. PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment.
Daemen BJ; Zwertbroek R; Elsinga PH; Paans AM; Doorenbos H; Vaalburg W
Eur J Nucl Med; 1991; 18(7):453-60. PubMed ID: 1915472
[TBL] [Abstract][Full Text] [Related]
18. [Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer].
Li H; Wu H; Wang Q; Han Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):500-3. PubMed ID: 24752096
[TBL] [Abstract][Full Text] [Related]
19. Urinary bladder leiomyosarcoma: staging with 18F-FDG PET/CT.
Makis W; Rakheja R; Nahal A; Hickeson M; Lisbona R
Clin Nucl Med; 2013 May; 38(5):e218-22. PubMed ID: 23377410
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
Maurer T; Souvatzoglou M; Kübler H; Opercan K; Schmidt S; Herrmann K; Stollfuss J; Weirich G; Haller B; Gschwend JE; Schwaiger M; Krause BJ; Treiber U
Eur Urol; 2012 May; 61(5):1031-8. PubMed ID: 22196847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
